Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide.
Studies were carried out in the rat in order to investigate whether cholinergic mechanisms may be involved in vasopressin (VP) release induced by metoclopramide (MCP). The intravenous injection of MCP induced dose-related increases in plasma VP levels in water-loaded rats. These effects were prevented by atropine sulphate, but not by pirenzepine hydrochloride indicating that activation of cholinergic receptors of M-2 type was possibly required for the biologic response.
Steardo
L
L
Department of Neurology, 2nd Medical School, University of Naples, Italy.
Iovino
M
M
Monteleone
P
P
Bevilacqua
M
M
Norbiato
G
G
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004347:Drug Interactions; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology*; D010890:Pirenzepine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000502:physiology*; D012636:Secretory Rate / Q000187:drug effects; D014667:Vasopressins / Q000378:metabolism*; D014867:Water / Q000008:administration & dosage
D011976:Receptors, Muscarinic; D014867:Water; D014667:Vasopressins; D010890:Pirenzepine; D001285:Atropine; D008787:Metoclopramide